REVOLAX™ SUB-Q
$59.00
| Packs | Discount (%) | For each |
|---|---|---|
| 1 - 2 | - | $59.00 |
| 3 - 10 | 1.69% | $58.00 |
| 11 - 20 | 3.39% | $57.00 |
| 21+ | 5.08% | $56.00 |
Brand:
REVOLAX™
Manufacturer:
Across Co.
Active Substance(s):
HYALURONIC ACID
Strength:
24mg/ml
Pack size:
1 x 1 ml Pre-Filled Syringe, 2 x 25G Needles
About the product
REVOLAX™ SUB-Q is provided as a sterile volume of 1.1 ml in a single-use glass syringe with two sterilized 25G mm needles. For REVOLAX™ Sub-Q, results will be effective for between 8 and 12 months.
REVOLAX™ SUB-Q is used in volumetric treatments, correction of deep wrinkles, correction of the nose, chin, cheeks, contouring.
REVOLAX™ Sub-Q has the thickest properties within the product line. With its advanced ability to mould, maintain structure, and longevity – it is recommended for the treatment of deep-sized to extremely severe wrinkles including nasolabial. This product also works best for cheek, chin, nose, and jawline augmentation that requires a thicker substance to fill.
REVOLAX™ uses high-purity non-animal hyaluronic acid, which is a 100% natural substance, optimally synchronizing with human skin tissues. The product is completely purified of the BDDE cross-linking agent, which ensures a high level of safety for the patient. REVOLAX™ is based on a unique cross-linking technology that does not require free hyaluronic acid to apply the physical properties of the gel formula. High viscoelasticity is one of the distinguishing features of REVOLAX™. This malleable consistency creates an immediate and lasting volume, and also allows the product to evenly distribute with a natural finish.
REVOLAX™ SUB-Q without Lidocaine is recommended for intradermal implantation for volume loss and morphological asymmetry of the face. It should be injected into deep subcutaneous.
Contraindications:
- Do not inject REVOLAX™ SUB-Q into the eye area (eye circle or eyelids).
- Do not inject REVOLAX™ SUB-Q into the blood vessels (intravascular).
- REVOLAX™ SUB-Q without Lidocaine should not be used in:
- Pregnant or nursing women
- Persons under 18 years of age
- Patients known to be hypersensitive to hyaluronic acid
- Patients who tend to develop hypertrophic scars
- REVOLAX™ SUB-Q should not be used in combination with laser therapy, chemical peeling, or skin abrasion.
- REVOLAX™ SUB-Q should not be used in areas with inflammatory and infectious skin problems.
After-care:
- Do not use in patients with coagulation disorders or in patients who have been treated with thrombolytic anticoagulants or platelet aggregation inhibitors within the previous 2 weeks.
- It is recommended to avoid taking aspirin, non-steroidal anti-inflammatory drugs, or high doses of vitamin C the week before the injection.
- Patients are advised not to wear makeup for 12 hours after the injection and to avoid extended exposure to sunlight, UV light, and extreme cold and heat for 2 weeks after the injection.